Novo Nordisk shares soar 7% as drugmaker sees copycat Wegovy gross sales easing in 2025
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss therapies Ozempic and Wegovy are footage whereas the corporate presents the annual report at…
